Isabelle Davignon Selected Research

tanezumab

1/2022	General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo-Controlled Trials.
12/2021	Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis.
1/2020	Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study.
1/2019	Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
9/2014	Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
7/2013	Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.
8/2012	Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Davignon Research Topics

Disease

6	Osteoarthritis 01/2022 - 08/2012
6	Pain (Aches) 12/2021 - 08/2012
3	Knee Osteoarthritis 01/2022 - 09/2014
3	Hip Osteoarthritis (Coxarthrosis) 12/2021 - 09/2014
2	Arthralgia (Joint Pain) 01/2020 - 01/2019
1	Bradycardia 01/2022
1	Hypesthesia (Numbness) 01/2022
1	Orthostatic Hypotension (Postural Hypotension) 01/2022
1	Paresthesia (Dysesthesia) 01/2022
1	Chronic Pain 09/2014

Drug/Important Bio-Agent (IBA)

7	tanezumabIBA 01/2022 - 08/2012
2	Analgesics (Analgesic Drugs)IBA 01/2019 - 08/2012
2	Prostaglandins AIBA 01/2019 - 08/2012
1	Monoclonal AntibodiesIBA 09/2014
1	Diclofenac (SR 38)FDA LinkGeneric 09/2014
1	Nerve Growth Factor (NGF)IBA 09/2014

Therapy/Procedure

1	Replacement Arthroplasty 01/2019